Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
Cytotherapy
; 20(10): 1227-1237, 2018 10.
Article
en En
| MEDLINE
| ID: mdl-30266521
ABSTRACT
Recent advances in immunotherapeutic modalities have profoundly changed the prospect of cancer treatment. These modalities mainly focus on modulating the immune response toward tumor cells by using monoclonal antibodies, cancer vaccines, adoptive cell transfer or combination of these methods. In the last few years, Iranian scientists have conducted several projects in these arenas. Here, we provide an overview of these studies and analyze the quality and trend of publications in each sub-specialty of the field. In addition, the contribution of different universities and scientific institutes is assessed. This study may benefit scientific community and policymakers to plan future cancer immunotherapies in Iran and other countries.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Vacunas contra el Cáncer
/
Investigación Biomédica
/
Tratamiento Basado en Trasplante de Células y Tejidos
/
Inmunoterapia
/
Neoplasias
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
En
Revista:
Cytotherapy
Asunto de la revista:
TERAPEUTICA
Año:
2018
Tipo del documento:
Article
País de afiliación:
Irán